Since the class-3 semaphorin-mediated inhibitory effect on developmental and tumor angiogenesis has been associated with their ability to counteract VEGF165 signaling, a prognostic value of determining VEGF/Sema3 signal ratio has been suggested in GBM [66]. This evidence concerns the gene VEGFA and glioblastoma.